{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,23]],"date-time":"2026-02-23T05:12:33Z","timestamp":1771823553040,"version":"3.50.1"},"reference-count":15,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2020,6,18]]},"DOI":"10.7759\/cureus.8689","type":"journal-article","created":{"date-parts":[[2020,6,18]],"date-time":"2020-06-18T21:55:00Z","timestamp":1592517300000},"source":"Crossref","is-referenced-by-count":2,"title":["Olanzapine and Lorazepam Used in the Symptomatic Management of Excited Catatonia Secondary to Anti-N-Methyl-D-Aspartate Receptor Encephalitis"],"prefix":"10.7759","author":[{"given":"Namita","family":"Neerukonda","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael","family":"Bliss","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Abtin","family":"Jafroodifar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Luba","family":"Leontieva","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1002\/ana.21050","article-title":"Paraneoplastic anti-N\u2010methyl\u2010D\u2010aspartate receptor encephalitis associated with ovarian teratoma","volume":"61","author":"Dalmau J","year":"2007","unstructured":"Dalmau J, T\u00fcz\u00fcn E, Wu Hy, et al.. Paraneoplastic anti-N\u2010methyl\u2010D\u2010aspartate receptor encephalitis associated with ovarian teratoma. Ann Neurol. 2007, 61:25-36. 10.1002\/ana.21050","journal-title":"Ann Neurol"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1016\/S1474-4422(10)70253-2","article-title":"Clinical experience and laboratory investigations in patients with anti-NMDAR encephalitis","volume":"10","author":"Dalmau J","year":"2011","unstructured":"Dalmau J, Lancaster E, Martinez-Hernandez E, Rosenfeld MR, Balice-Gordon R. Clinical experience and laboratory investigations in patients with anti-NMDAR encephalitis. Lancet Neurol. 2011, 10:63-74. 10.1016\/S1474-4422(10)70253-2","journal-title":"Lancet Neurol"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1176\/appi.neuropsych.18010005","article-title":"Anti-N-methyl-D-aspartate receptor encephalitis: a review of psychiatric phenotypes and management considerations: a report of the American Neuropsychiatric Association committee on research","volume":"31","author":"Sarkis RA","year":"2019","unstructured":"Sarkis RA, Coffey MJ, Cooper JJ, Hassan I, Lennox B. Anti-N-methyl-D-aspartate receptor encephalitis: a review of psychiatric phenotypes and management considerations: a report of the American Neuropsychiatric Association committee on research. J Neuropsychiatry Clin Neurosci. 2019, 31:137-142. 10.1176\/appi.neuropsych.18010005","journal-title":"J Neuropsychiatry Clin Neurosci"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1176\/appi.ajp.2010.10020181","article-title":"Anti-NMDA receptor encephalitis: diagnosis, psychiatric presentation, and treatment","volume":"168","author":"Chapman MR","year":"2011","unstructured":"Chapman MR, Vause HE. Anti-NMDA receptor encephalitis: diagnosis, psychiatric presentation, and treatment. Am J Psychiatry. 2011, 168:245-251. 10.1176\/appi.ajp.2010.10020181","journal-title":"Am J Psychiatry"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1017\/S1092852919001573","article-title":"Catatonia secondary to anti-N-methyl-D-aspartate receptor (NMDAr) encephalitis: a review","author":"Macedo IM","year":"2019","unstructured":"Macedo IM, Marques JG. Catatonia secondary to anti-N-methyl-D-aspartate receptor (NMDAr) encephalitis: a review. CNS Spectr. 2019, 1-18. 10.1017\/S1092852919001573","journal-title":"CNS Spectr"},{"key":"ref6","article-title":"Anti-N-methyl-D-aspartate receptor encephalitis: a targeted review of clinical presentation, diagnosis, and approaches to psychopharmacologic management","volume":"26","author":"Kruse JL","year":"2014","unstructured":"Kruse JL, Jeffrey JK, Davis MC, Dearlove J, IsHak WW, Brooks JO. Anti-N-methyl-D-aspartate receptor encephalitis: a targeted review of clinical presentation, diagnosis, and approaches to psychopharmacologic management. Ann Clin Psychiatry. 2014, 26:111-119.","journal-title":"Ann Clin Psychiatry"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-0447.1996.tb09814.x","article-title":"Catatonia. I. rating scale and standardized examination","volume":"93","author":"Bush G","year":"1996","unstructured":"Bush G, Fink M, Petrides G, Dowling F, Francis A. Catatonia. I. rating scale and standardized examination. Acta Psychiatr Scand. 1996, 93:129-136. 10.1111\/j.1600-0447.1996.tb09814.x","journal-title":"Acta Psychiatr Scand"},{"key":"ref8","article-title":"Wechsler abbreviated scale of intelligence","volume":"48","author":"Stano JF","year":"2004","unstructured":"Stano JF. Wechsler abbreviated scale of intelligence. Rehabil Couns Bull. 2004, 48:56.","journal-title":"Rehabil Couns Bull"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1002\/9780470479216.corpsy0573","article-title":"Minnesota multiphasic personality inventory","author":"Butcher JN","year":"2010","unstructured":"Butcher JN. Minnesota multiphasic personality inventory. The Corsini Encyclopedia of Psychology. Weiner IB, Craighead WE (ed): John Wiley & Sons, Inc, New Jersey; 2010. 1-3. 10.1002\/9780470479216.corpsy0573"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1176\/ajp.107.8.577","article-title":"Uses of the thematic apperception test","volume":"107","author":"Murray HA","year":"1951","unstructured":"Murray HA. Uses of the thematic apperception test. Am J Psychiatry. 1951, 107:577-581. 10.1176\/ajp.107.8.577","journal-title":"Am J Psychiatry"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1111\/j.1532-5415.2005.53221.x","article-title":"The Montreal Cognitive Assessment, MoCA: a brief screening tool for mild cognitive impairment","volume":"53","author":"Nasreddine ZS","year":"2005","unstructured":"Nasreddine ZS, Phillips NA, B\u00e9dirian V, et al.. The Montreal Cognitive Assessment, MoCA: a brief screening tool for mild cognitive impairment. J Am Geriatr Soc. 2005, 53:695-699. 10.1111\/j.1532-5415.2005.53221.x","journal-title":"J Am Geriatr Soc"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1007\/s00415-012-6457-y","article-title":"Spontaneous recovery from anti-NMDAR encephalitis","volume":"259","author":"Evoli A","year":"2012","unstructured":"Evoli A, Spinelli P, Frisullo G, Alboini PE, Servidei S, Marra C. Spontaneous recovery from anti-NMDAR encephalitis. J Neurol. 2012, 259:1964-1966. 10.1007\/s00415-012-6457-y","journal-title":"J Neurol"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1212\/01.wnl.0000278388.90370.c3","article-title":"Anti-NMDA receptor encephalitis in Japan: long-term outcome without tumor removal","volume":"70","author":"Iizuka T","year":"2008","unstructured":"Iizuka T, Sakai F, Ide T, et al.. Anti-NMDA receptor encephalitis in Japan: long-term outcome without tumor removal. Neurology. 2008, 70:504-511. 10.1212\/01.wnl.0000278388.90370.c3","journal-title":"Neurology"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1016\/j.psym.2013.06.002","article-title":"Psychiatric manifestations of anti-NMDA receptor encephalitis: neurobiological underpinnings and differential diagnostic implications","volume":"55","author":"Maneta E","year":"2014","unstructured":"Maneta E, Garcia G. Psychiatric manifestations of anti-NMDA receptor encephalitis: neurobiological underpinnings and differential diagnostic implications. Psychosomatics. 2014, 55:37-44. 10.1016\/j.psym.2013.06.002","journal-title":"Psychosomatics"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1136\/bcr-2013-010461","article-title":"Autoimmune limbic encephalitis presenting as relapsing psychosis","volume":"2013","author":"Hopkins SA","year":"2013","unstructured":"Hopkins SA, Moodley KK, Chan D. Autoimmune limbic encephalitis presenting as relapsing psychosis. BJM Case Rep. 2013, 2013:bcr2013010461. 10.1136\/bcr-2013-010461","journal-title":"BJM Case Rep"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/32516-olanzapine-and-lorazepam-used-in-the-symptomatic-management-of-excited-catatonia-secondary-to-anti-n-methyl-d-aspartate-receptor-encephalitis","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,9]],"date-time":"2024-02-09T19:26:46Z","timestamp":1707506806000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/32516-olanzapine-and-lorazepam-used-in-the-symptomatic-management-of-excited-catatonia-secondary-to-anti-n-methyl-d-aspartate-receptor-encephalitis"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,6,18]]},"references-count":15,"URL":"https:\/\/doi.org\/10.7759\/cureus.8689","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2020,6,18]]}}}